For my initial coverage of Labcorp, I'm calling it a hold, and an opportunity to earn a $0.72/share quarterly dividend on the leading clinical lab company in the US. The firm shows future growth ...
Laboratory Corp (NYSE: LH) reported third-quarter 2025 adjusted earnings per share of $4.18 on Tuesday, up from $3.50 a year ago, beating the consensus of $4.18. Sales increased 8.6% year-over-year to ...
In the preceding three months, 8 analysts have released ratings for Labcorp Hldgs (NYSE:LH), presenting a wide array of perspectives from bullish to bearish. Summarizing their recent assessments, the ...
Labcorp Holdings Inc. LH, or Labcorp’s strong focus on key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, is poised to help it grow in the upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback